United Therapeutics
UTHR
$272.69
Share price
1.08%
Change (1 day)
27.19%
Change (1 year)
Categories
United Therapeutics (UTHR) - Cash on Hand
Cash on Hand as of March 2024 : $2.70 B
According to United Therapeutics's latest financial reports the company has $2.70 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
United Therapeutics - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $2.99 B | 5.47% |
| 2022-12-31 | $2.83 B | 47.03% |
| 2021-12-31 | $1.93 B | 5.22% |
| 2020-12-31 | $1.83 B | 23.49% |
| 2019-12-31 | $1.48 B | 4.94% |
| 2018-12-31 | $1.41 B | 52.67% |
| 2017-12-31 | $0.92 B | -11.74% |
| 2016-12-31 | $1.05 B | 10.17% |
| 2015-12-31 | $0.95 B | 37.13% |
| 2014-12-31 | $0.69 B | 0.24% |
| 2013-12-31 | $0.69 B | 44.8% |
| 2012-12-31 | $0.47 B | 18.77% |
| 2011-12-31 | $0.40 B | -35.66% |
| 2010-12-31 | $0.62 B | 173.25% |
| 2009-12-31 | $0.22 B | -2.78% |
| 2008-12-31 | $0.23 B | -18.62% |
| 2007-12-31 | $0.29 B | 27.36% |
| 2006-12-31 | $0.22 B | 81.5% |
| 2005-12-31 | $0.12 B | 51.58% |
| 2004-12-31 | $82.78 M | 20.75% |
| 2003-12-31 | $68.56 M | -44.1% |
| 2002-12-31 | $0.12 B | 118.83% |
| 2001-12-31 | $56.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 368.65% | 🇺🇸 USA |
 Eli Lilly LLY | $2.58 B | -4.49% | 🇺🇸 USA |
 Baxter BAX | $3.02 B | 11.75% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.26 B | 168.26% | 🇺🇸 USA |
 Cardinal Health CAH | $3.71 B | 37.31% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $5.17 B | 91.11% | 🇬🇧 UK |
 Cytokinetics
CYTK | $0.61 B | -77.29% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 19.14% | 🇮🇱 Israel |